Atlas Trials

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

Clinical trial NCT05333458 · RECRUITING

Trial details

NCT number
NCT05333458
Sponsor
National Cancer Institute (NCI)
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Alveolar Soft Part SarcomaAdvanced Soft Tissue SarcomaMetastatic Alveolar Soft Part SarcomaRefractory Alveolar Soft Part SarcomaUnresectable Alveolar Soft Part Sarcoma
Start date
2022-08-29
Primary completion
2027-05-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.